RCM
JAZZ icon

Radnor Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Radnor Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Sell
8,965
-25
-0.3% -$5.48K 0.3% 92
2026
Q1 		$1.7M Hold
8,990
– – 0.25% 107
2025
Q4 		$1.53M Buy
8,990
+760
+9% +$117K 0.23% 108
2025
Q3 		$1.08M Sell
8,230
-250
-3% -$30K 0.17% 147
2025
Q2 		$900K Sell
8,480
-60
-0.7% -$6.52K 0.14% 166
2025
Q1 		$1.06M Buy
8,540
+615
+8% +$80.2K 0.18% 140
2024
Q4 		$976K Sell
7,925
-55
-0.7% -$6.48K 0.16% 158
2024
Q3 		$889K Sell
7,980
-245
-3% -$26.8K 0.13% 181
2024
Q2 		$878K Buy
8,225
+16
+0.2% +$1.76K 0.27% 84
2024
Q1 		$989K Hold
8,209
– – 0.17% 148
2023
Q4 		$1.01M Sell
8,209
-775
-9% -$96.7K 0.19% 136
2023
Q3 		$1.16M Buy
8,984
+200
+2% +$26.6K 0.23% 110
2023
Q2 		$1.09M Buy
+8,784
New +$1.18M 0.47% 47

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Radnor Capital Management's JAZZ Position: Q2 2026 in Review

Radnor Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.28% in Q2 2026, selling an estimated $5.48K and leaving 8,965 shares worth $2.16M. The position accounts for 0.3% of the portfolio, ranked #92.

Radnor Capital Management first reported a position in JAZZ in Q2 2023 and has held it in 13 quarters since. 86 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Radnor Capital Management held 8,965 shares of Jazz Pharmaceuticals worth $2.16M as of Q2 2026.
  • Radnor Capital Management sold 25 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.48K.
  • Jazz Pharmaceuticals made up 0.3% of Radnor Capital Management's portfolio in Q2 2026, its #92 holding.
  • Radnor Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 86 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.